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Background/aim: Common variable immunodeficiency (CVID) is a heterogeneous primary deficiency characterized by
hypogammaglobulinemia, recurrent infections, an increased risk of autoimmune disease, malignancy, and chronic inflammation.
Proteinuria is one of the most important prognostic factors causing progression in kidney disease. Proteinuria causes tubulotoxicity,
activates inflammatory markers that cause fibrosis, and consequently nephropathy progression. The data is scant in the literature
regarding the inflammation and nephropathy in CVID. Hence, in the present study, we aimed to investigate the relationship between
tubular dysfunction, proteinuria, and inflammation in patients with CVID.
Materials and methods: This was a cross-sectional study involving 27 patients with CVID (15 females, 12 males; mean age, 39.88 ±
13.47 years) and 18 control subjects (10 females, 8 males; mean age, 33.83 ± 7.97 years). Patients were evaluated for kidney functions
including glomerular filtration rate, fractional excretion of sodium, metabolic acidosis, serum/urine anion gap, 24-h urine proteinuria
and, were grouped in terms of proteinuria. Blood samples obtained from the patients with CVID were taken into 2 mL EDTA tube to
evaluate peripheral NK cell subgroups according to CD56 and CD16 expression and CD3, CD4, CD 8 expression to determine subtypes
T cells. These cells were evaluated by flow cytometry technique.
Results: Urinary density, fractional excretion of sodium, proteinuria, and metabolic acidosis are found to be higher in patients with
CVID when compared to healthy controls. In the bivariate correlation analysis, proteinuria was positively correlated with age (r = 0.496,
p = < 0.001), CD8+T cells percentage (r = 0.427, p = 0.02). Albumin, CRP, and CD8+T cell percentage were found to be independent
variables of proteinuria.
Conclusion: Increased chronic ongoing inflammation was found to be associated with proteinuria in patients with CVID. Hence, in
routine outpatient clinics, proteinuria should not be overlooked in this group of patients.
Key words: Chronic inflammation, proteinuria, common variable immunodeficiency

1. Introduction
Common variable immunune deficiency (CVID) refers
to a group of heterogeneous disorders that are often due
to inherited defects of the immune system. Patients with
CVID are frequently susceptible to recurrent infections,
autoimmunity, lymphoproliferation, and malignancy [1].
Because of the perception of CVID as rare congenital
diseases, heterogeneity of diseases, and lack of awareness,
delay in diagnosis is frequent. Partial elimination of
problems in access to immune replacement therapy,
effective treatment of infections with antibiotics, and
introduction of targeted monoclonal antibodies have
significantly reduced mortality in CVID patients. As a

result, the management of the complications and the
quality of life has become more important with increased
life expectancy in CVID patients. Although recurrent and
widespread upper and lower respiratory tract infections
and increased autoimmunity, lymphoproliferation, and
especially increased lymphomalignies are well-defined
complications of immunodeficiencies, renal complications
are relatively rare and overlooked in this group of patients
[2].
Increased inflammatory markers such as C-reactive
protein, interleukin (IL)-1, IL-6, and tumor necrosis
factor (TNF)-α, interstitial cellular adhesion molecule-1,
vascular cellular adhesion molecule-1, CD8+T cells,
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natural killer (NK) cells, and E-selectin are associated
with the development of nephropathy in many chronic
diseases [3]. Inflammation and inflammatory molecules
are also thought to affect glomerular functions through
alternations in vascular permeability, vasodilator, and
vasoconstrictor mechanisms, extracellular matrix
dynamics, and the proliferation of mesangial, endothelial,
and vascular smooth muscle cells, as well as the induction
of cytotoxicity, apoptosis, and necrosis in the pathogenesis
and progression of chronic kidney disease (CKD) [4].
Proteinuria is one of the most important prognostic
factors causing progression in kidney disease. Proteinuria
causes tubulotoxicity, activates inflammatory markers that
cause fibrosis, and consequently nephropathy progression.
Most studies have found that better renal outcomes are
associated with agents that lower proteinuria [5,6]. For this
reason, depending on the underlying etiology, reduction
of proteinuria, by the renin-angiotensin-aldosterone
blockade, immunosuppressive treatment, and diet
regimens, is one of the important parts of the treatment to
slow the progression [7].
To date the data regarding the nephropathy in CVID is
scant. Hence, we aimed to investigate the relation between
the tubular dysfunction, proteinuria, and inflammatory
cells including T and NK cells in patients with CVID.
2. Material and methods
The study group included 27 patients with CVID (male
(M): 12 (44.4%)/female (F): 15 (55.6%), age: 39.88 ± 13.47)
who follow up at regular basis and 18 patients (F/M: 10/8,
age: 33.83 ± 7.97) as a control group. The study protocol
was approved by the ethics committee of the university
(sate: 16.11.2018; approval number: 2018/1574). Informed
consent was obtained from study participants. The
diagnosis of CVID was made according to the updated
diagnostic criteria of ESID [2].
Demographic and clinical data were retrieved from
individual medical files, which all recorded at the first visit
of patients including, sex, age, diagnostic delay, detailed
family history, and all other necessary information. Initial
immunological workup and other diagnostic investigations
to expose exact diagnosis and concurrent complications
and/or disorders were also recorded.
Venous blood samples for biochemical analyses were
drawn after at least 10 h of fasting before taking any
medication. All biochemical analyses were undertaken
using an oxidase-based technique at Roche/Hitachi
Modular System (Mannheim, Germany) in the Central
Biochemistry Laboratory of the Necmettin Erbakan
University Meram School of Medicine.
Quantitative determination of serum immunoglobulins
(IgG, IgM, IgA, and IgE) was made through particleenhanced immunonephelometry using the Siemens BN
II/BN ProSpec system (New York, USA). Blood samples

obtained from the patients with CVID were taken into 2
mL EDTA tube to evaluate peripheral NK cell subgroups
according to CD56 and CD16 expression and CD3, CD4,
CD8 expression to determine subtypes T cells. These
cells were measured by the BD FACSCanto II 8-color
configuration flow cytometer system (California, USA)
with fluorescently labeled antibodies.
The eGFR values of the patients were measured
by three different methods. The first method was The
modification of diet in renal disease (MDRD) formula:
186 × Serum Cr–1.154 × age–0.203 × 1.212 (if the patient is
black) × 0.742 (if female). In the second technique, eGFR
values was measured by Cockcroft–Gault formula: CrCl
mL/min = (140 – age) × (weight, kg) × (0.85 if female)/
(72 × Cr). Lastly, the chronic kidney disease epidemiology
collaboration (CKD-EPI) formula was used to calculated
eGFR values: 141 × min (Scr/κ (0.7 for females and 0.9
for males))α (–0.329 for females and –0.411 for males) × max (Scr/κ)–1.209 ×
0.993Age × 1.018 (if female) × 1.159 (if black). Urine density,
urine ph, fractionated sodium excretion, and serum/urine
anion gap were calculated to evaluate the tubule functions
of the patients. The normal range for serum anion gap
was accepted as > 12 +/– 4 mEq/L, the negative urine gap
was accepted as (–20)–(–50) mEq/L [8,9]. Proteinuria in
patients with CVID was assessed by 24-h total protein
excretion and was defined as an excretion above 150 mg/
day in 24-h urinalysis [10].
Complete blood counts with automated differential
counts, which included total white blood cells, neutrophils,
and lymphocytes, were obtained. The neutrophil to
lymphocyte ratio and platelet to lymphocyte ratio were
calculated as the ratio of the neutrophils and platelets to
lymphocytes, respectively, with both obtained from the
same automated blood sample at the onset of the study.
Clinical and experimental data were analyzed using
Statistical Package for Social Sciences for Windows v: 15.0
(SPSS Inc., Chicago, Illinois, USA). Descriptive statistics
for each variable were determined. Data were expressed
as mean ± standard deviation. Results for continuous
variables without normal distribution were presented
as median (interquartile range (IQR)). A statistically
significant difference between the groups was determined
by the χ2 test for categorical variables. Nonparametric
statistics (Mann–Whitney U) and parametric statistics
(independent sample t-test) were all used for continuous
variables. Associations between the variables were
explored using Spearman’s rho test. Linear regression
analysis was also performed to define variables associated
with proteinuria. A statistically significant difference was
considered when p-value ≤ 0.05.
3. Results
Demographic, clinical characteristics and biochemical
parameters of 27 patients with CVID and 18 healthy control
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subjects were depicted in Tables 1 and 2. There were no
significant differences concerning the following variables
between patients and control subjects; sex, age, eGFR
values, and serum levels of creatinine. When examined in
terms of different methods, eGFR values of both groups,
by Cockcroft–Gault, CKD-EPI, and MDRD, were similar.
(p: 0.500, p: 0.739, p: 0.753, respectively). Patients with
CVID had significantly higher urinary density, fractional
excretion of sodium. Also, 24-h proteinuria and metabolic
acidosis are found to be higher in patients with CVID
when compared to healthy controls (Table 2). When
we evaluated the patients with metabolic acidosis for
differential diagnosis, we found that there was an acidosis
with normal anion gap. In addition, we evaluated patients
with acidosis in terms of urinary anion gap results and we
found a positive urinary anion gap.
When patients with CVID were divided into 2 groups
according to proteinuria, there were significant differences
between the two groups in terms of age and platelet/
lymphocyte ratio (p: 0.020 and p: 0.031, respectively)
(Table 3).
In the bivariate correlation analysis in patients with
CVID, proteinuria was positively correlated with age,
CD8+T cells percentage and, negatively correlated with
albumin and platelet/lymphocyte ratio (Table 4).
We also performed a linear regression analysis to
define variables that are independently associated with

proteinuria (Table 5). Age, albumin, CRP, CD8+T cells,
and platelet/lymphocyte ratio were included in this model.
Albumin, CRP, and CD8+ T cell percentage were found to
be the independent predictor of proteinuria.
4. Discussion
There were 3 main findings of the present study. First,
renal dysfunction including proteinuria, metabolic
acidosis, and urinary excretion of sodium and urine
density was higher in patients with CVID. Second, age
and CD8+T cells percentage are positively correlated with
proteinuria. Lastly, low albumin, high CRP, high CD8+ T
cell percentage are found to be independent predictors of
proteinuria in patients with CVID.
In 1993, Hermaszewski et al. [11] presented the study
that first mentioned renal involvement and complications
in patients with immune deficiency. In this study in which
240 patients with CVID were evaluated, only 5 patients had
renal involvement. Of these, 2 patients had chronic kidney
disease, 1 patient had nephrotic syndrome and 2 patients
had the nephritic syndrome. Later, in different studies,
many conditions such as renal granuloma, focal segmental
glomerulonephritis, membranous nephropathy (MN),
membranoproliferative glomerulonephritis (MPGN), renal
amyloidosis, nephrotic syndrome, various tubulopathies,
and end-stage renal failure were also identified in patients
with CVID [12–18]. In 2014, Sarkar et al. [19] found

Table 1. Demographic, clinical, and laboratory variables and peripheral lymphocyte subset analysis of patients
with CVID.
Demographic and clinical variables of the patients
Age (year)

39.88 ± 13.47

Sex, F, n (%)

15 (55.6)

Age at diagnosis (year)

32.36 ± 14.86

Diagnostic delay (month)

90 (0–294)

Splenomegaly, n (%)

16 (57.1)

Bronchiectasis, n (%)

15 (53.6)

Laboratory parameters of the patients
IgG, at diagnosis, (g/L)

2.76 (0.33–6.90)

Neutrophil (103/μL)

3395 (1000–12500)

IgM at diagnosis, (g/L)

0.25 (0.006–5.99)

Lymphocyte (10 /μL)

1315 (400–8900)

IgA at diagnosis, (g/L)

0.25 (0.006–1.90)

Platelet (103/mm3)

216607 ± 105563

IgE at diagnosis, (g/L)

17.55 (5–220)

Neutrophil/Lymphocyte ratio

2.84 ± 1.68

CRP (mg/L)

0.73 (0–18.7)

Platelet/Lymphocyte ratio

160.44 ± 121.32

MPV (fL)

9.80 (6.90–17.40)

3

Peripheral lymphocyte subset analysis of the patients
CD3+T cells (%)

78.02 ± 11.74

CD16-56+ NK cells (%)

8.88 ± 6.19

CD4+T cells (%)

35.30 ± 15.07

IgM- CD27+ B cells (%)

1.75 (0–27)

CD8 T cells (%)

36.5 (19–74)

CD19+B cells (%)

7.35 ± 5.90

+

CVID: Common variable immune deficiency, F: female, Ig: immunoglobulin, CD: cluster of differentiation, NK:
natural killer, MPV: mean corpuscular volume, CRP: C-reactive protein.
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Table 2. Comparasion of demografic and laboratory variables of CVID patients and the control group.
Variables

Total

CVID (n: 27)

Control (n: 18)

P values

Age (years)

37.51 ± 11.91

39.88 ± 13.47

33.83 ± 7.97

0.093

Sex, F, n (%)

25 (54.4)

15 (55.6)

10 (55.6)

0.895

GFR (mL/min/1.73m2)

111.45 ± 20.14

109.74 ± 22.56

113.90 ± 15.96

0.500

CKD-EPI

115.58 ± 31.73

123.14 ± 37.23

119.90 ± 21.37

0.739

The Cockcroft–Gault Equation

109.69 (52.6–193.58)

109.89 (52.6–193.58)

108.61 (80.03–144.43)

0.753

MDRD

109.69 (52.6–193.58)

109.89 (52.6–193.58)

108.61 (80.03–144.43)

0.753

Creatinine (mg/dL)

0.78 ± 0.19

0.77 ± 0.21

0.80 ± 0.16

0.573

Urinary pH

5.5 (5.0–7.0)

5.50 (5.0–6.50)

5.5 (5.0–7.0)

0.875

Urinary density (g/mL)

1.017 (1.005– 1.029)

1018.23 ± 5.4

1013.75 ± 5.7

0.014

Metabolic acidosis, n (%)

8 (21.62)

8 (28.6)

0

0.044

24-h urine protein (mg/L)

96.44 (19.04–1635)

136.69 (19.04–1635.4)

75 (25–100)

0.007

FENa(%)

0.76 (0.26–1.86)

0.83 (0.41–1.86)

0.61 (0.26–0.98)

0.014

CVID: common variable immune deficiency, F: female, GFR: glomerular filtration rate, CKD-EPI: the chronic kidney disease
epidemiology collaboration, MDRD: the modification of diet in renal disease, FENa: the fractional excretion of sodium.

Table 3. Comparision of CVID patients according to the presence of proteinuria.
Variables

Patients with proteinuria
(n: 16)

Patients without proteinuria
(n: 11)

p

Sex (female), n (%)

7 (43.8)

8 (66.7)

0.229

Age (years)

34.88 ± 13.67

46.54 ± 10.29

0.020

Age at diagnosis (year)

27.75 ± 15.31

38.50 ± 12.27

0.137

Diagnostic delay (month)

101 (0–294)

48 (0–228)

0.100

IgG, at diagnosis, (g/L)

3.60 (1.17–6.90)

1.85 (0.33–6.80)

0.205

IgM at diagnosis, (g/L)

0.27 (0.08–3.16)

0.23 (0.06–5.99)

0.945

IgA at diagnosis, (g/L)

0.29 (0.06–1.90)

0.22 (0.06–1.21)

0.066

IgE at diagnosis, (g/L)

18.35 (5.0–220)

14.20 (5.0–19.0)

0.053

Neutrophil count (10 /μL)

3385 (1000–5300)

3510 (1900–12500)

0.347

Lymphocyte count (103/μL)

1145 (400–3800)

1705 (800–8900)

0.074

Lymphopenia (Lymphocyte <1000/mm³), n (%)

6 (37.5)

2 (16.7)

0.227

Platelet count (103/mm3)

211625 ± 78444

193250 ± 137393

0.779

CD3 T cells (%)

77.56 ± 13.02

78.63 ± 10.33

0.816

CD4+T cells (%)

37.0 ± 16.74

33.04 ± 12.86

0.502

CD8 T cells (%)

35 (19–74)

37 (23.70–70)

0.450

CD19+ B cells (%)

5.5 (0–14.0)

7.0 (0–21.0)

0.335

CD16 -56 NK cells (%)

10.13 ± 6.83

7.21 ± 5.03

0.224

IgM CD27 B cells (%)

2.65 (0–27)

0.8 (0–11.6)

0.059

Platelet/Lymphocyte ratio

202.56 ± 139.69

104.29 ± 59.15

0.031

Splenomegaly, n (%)

9 (56.3)

7 (43.8)

0.912

Bronchiectasis, n (%)

8 (50)

7 (58.3)

0.662

3

+

+

+

–

+

+

CVID: common variable immune deficiency, Ig: immunoglobulin, CD: cluster of differentiation, NK: natural killer.
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Table 4. Bivariate correlation results between proteinuria and
other parameters in patients with CVID.
Parameters

r

S

P value

Age (years)

0.496

< 0.001

CD8 T cells (%)

0.427

0.02

Platelet/Lymphocyte ratio

–0.585

0.01

Albumin (g/dL)

–0.642

< 0.001

+

especially for diseases such as osteomalacia, rickets, and
osteoporosis due to impaired proximal tubule functions
might be required.
There are many reasons such as infection, immune
dysfunction, autoimmunity, delay in diagnosis and
treatment, capillary leakage syndrome, and environmental
toxins that can increase chronic ongoing inflammation in
CVID patients [20]. In healthy individuals, albumin is a late
reacting negative acute-phase protein and is reabsorbed
by the proximal tubule [21]. In patients with proteinuria,
protein leakage activates a series of the detrimental
intracellular signaling cascade in tubular cells. As a result,
an inflammatory microenvironment is created by the
hyperproduction of numerous chemocytokines to increase
the migration of immune cells [22]. It has been claimed that
permeability factors, which are produced due to primary T
cell disorder in patients with CVID and cause disruption
in glomerular podocyte function, may contribute to the
development of nephrotic syndrome [23,24]. Also, when
CD8+ T cells are activated, almost all cells express MHC
class I molecules, so they have the potential to cause tissue
damage. Therewithal activated CD8+ T cells can produce
very high levels of tumor necrosis factor (TNF) and IFN-γ
that can contribute directly and/or indirectly to target cell
destruction in autoimmune diseases [25]. In the present
study, we found a positive correlation between proteinuria
and CD8+T cells. In addition to this data, we found CRP
and CD8+T cells as predictors of proteinuria in linear
regression analysis. These findings may suggest that
proteinuria occurs as a result of increased inflammation.
Platelet/lymphocyte ratio is an easy-to-calculate,
repeatable, and simple measurement with predictive
properties in acute inflammation and thrombotic events
[26]. Increased platelet/lymphocyte ratio is associated
with disease activity in some malignancy, rheumatological

CVID: common variable immune deficiency, CD: cluster of
differentiation.

findings compatible with chronic tubulointerstitial
nephritis, such as tubular degeneration, interstitial fibrosis,
and atrophied tubules due to lymphomononuclear cell
infiltration, when the patient with CVID evaluated by
biopsy due to renal failure. Similarly, Capistrano et al.
[18] demonstrated the presence of impaired tubular
function in patients with CVID, such as decreased urinary
concentration and decreased acidification capacity. In
our study, we found that the number of patients with
proteinuria and metabolic acidosis was higher in patients
with CVID than the control group. In addition to these
findings, FENa was significantly higher than the control
group, and in patients with metabolic acidosis, the serum
anion gap was in the normal range, while the urine anion
gap was not negative. These results show that patients with
humoral immune deficiency are also at risk for interstitial
and tubular renal diseases. This situation can be explained
by increased inflammation and T cell infiltration [18].
Also, patients with metabolic acidosis have a urinary ph
value of 5.5 or below, suggesting a proximal tubulopathy in
these patients. In this context, close follow-up of patients

Table 5. Variables of proteinuria in patients with CVID.
Standardized beta
coefficients

t

P value

95% CI

Age (years)

0.015

0.110

0.913

–6.001–6.671

CD8 T cells (%)

0.275

2.168

0.042

0.272–13.152

Albumin (g/dL)

–0.373

–2.341

0.029

–572.686–33.836

CRP (mg/L)

0.455

2.990

0.007

3.225–17.959

CD8+T cells (%)

0.275

2.228

0.036

0.464–12.998

Albumin (g/dL)

–0.380

–2.682

0.014

–548.252–70.055

CRP (mg/L)

0.453

3.084

0.005

3.449–17.605

Parameters
Step 1
+

Step 2

CVID: common variable immune deficiency, CD: cluster of differentiation, CRP: C-reactive protein.
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disease, and psychiatric disorder [27–30]. However, unlike
these data, in our study, patients with proteinuria had a
statistically lower platelet/lymphocyte ratio. This difference
may be due to the frequent occurrence of autoimmune
cytopenias due to immune dysregulation in patients with
CVID. As is known, immune dysregulation in patients with
CVID usually manifests with immune thrombocytopenia
[31–33]. Also, thrombocytopenia may be due to splenic
sequestration or autoimmunity in addition to immune
dysregulation. Our group reported that low platelet count
is a risk factor for bronchiectasis in patients with CVID
[34]. In our study, platelet values were found to be lower
in the group with proteinuria, although not statistically
significant. Therefore, the negative correlation between
platelet/lymphocyte ratio and proteinuria may be caused
by thrombocytopenia. This result may be an indirect
indication that immune dysregulation or autoimmunity
causes impaired kidney function.
It is obvious that as the disease duration and patient
age increases, patients will be exposed to inflammation
for a longer period. Although there is a marked decrease
in the frequency of infection with immunoglobulin
replacement therapies (IGRT) [35], the risk of developing
gastrointestinal
infections
and/or
complications,
malignancy, and granulomatosis disease is not affected
by IGRT [36,37]. Besides, with increasing age; renal load

increases due to the risk factors such as contrast imaging,
the use of immunosuppressive drugs (such as steroid,
cyclosporine, and nonsteroidal antiinflammatory drugs).
Therefore, these patients become more sensitive to kidney
disorders. In our study, patients with proteinuria were
significantly older than patients without proteinuria.
And, in statistical analysis, we found a positive correlation
between age and proteinuria in patients with CVID.
In conclusion, in the present study, we demonstrated
that patients with CVID have a higher risk of nephropathy
and proteinuria. Our findings suggest that nephropathy
may be more associated with tubulopathy, while we
observed that proteinuria is associated with increased
inflammation. Therefore, we think that patients who are
followed-up with a CVID diagnosis should be monitored
for nephropathy and related complications. It should
also be considered that proteinuria may be an indirect
indicator of increased inflammation in these patients.
Further randomized and controlled studies evaluating the
kidney functions in patients with CVID are needed.
Informed consent
The study protocol was approved by the Ethics committee
of the Necmettin Erbakan University (Date: 16.11.2018;
approval number: 2018/1574). Informed consent was
obtained from study participants.
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